COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1516: Articles 15151-15160  | Next

Serial interval of COVID-19 and the effect of Variant B.1.1.7: analyses from a prospective community cohort study (Virus Watch).
Geismar, C. R., Fragaszy, E., Nguyen, V. G., Fong, W. L. E., Shrotri, M., Beale, S., Rodger, A., Lampos, V., Byrne, T. E., Kovar, J., Navaratnam, A., Patel, P., Aldridge, R. W., Hayward, A., Virus Watch Collaborative
10.1101/2021.05.17.21257223 — Posted: 2021-05-17
The SARS-CoV-2 B.1.351/V2 variant is outgrowing the B.1.1.7/V1 variant in French regions in April 2021
Roquebert, B., Trombert-Paolantoni, S., Haim-Boukobza, S., Lecorche, E., Verdurme, L., Foulonge, V., Sofonea, M. T., Alizon, S.
10.1101/2021.05.12.21257130 — Posted: 2021-05-17
Global mapping of RNA homodimers in living cells
Gabryelska, M. M., Kudla, G.
10.1101/2021.05.13.444021 — Posted: 2021-05-17
Current challenges of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies among blood donors: A scoping review
Saeed, S., Uzicanin, S., Lewin, A., Lieshout-Krikke, R., Faddy, H., Erikstrup, C., Osiowy, C., Seed, C., Steele, W., Davidson, K., Custer, B., O'Brien, S. F.
10.1101/2021.05.13.21257177 — Posted: 2021-05-17
SARS-CoV-2 convergent evolution cannot be reliably inferred from phylogenetic analyses
Jo, Y.-S., Tamuri, A. U., Towers, G. J., Goldstein, R. A.
10.1101/2021.05.15.444301 — Posted: 2021-05-17
Verification of SARS-CoV-2-Encoded small RNAs and contribution to Infection-Associated lung inflammation
Zhang, C., Liu, C., Jiang, L., Cui, B. L., Li, Y. C., Song, X. G., Xu, R., Geng, N. X., Luan, X. C., Chen, Y., Zhu, L. B., Zhu, W.
10.1101/2021.05.16.444324 — Posted: 2021-05-17
Predictors of Social Distancing and Mask-Wearing Behavior: Panel Survey in Seven U.S. States
Nikolov, P., Pape, A., Tonguc, O., Williams, C.
10.1101/2021.05.04.21256574 — Posted: 2021-05-17
REACT-1 round 11 report: low prevalence of SARS-CoV-2 infection in the community prior to the third step of the English roadmap out of lockdown
Riley, S., Haw, D. J., Walters, C. E., Wang, H., Eales, O., Ainslie, K. E. C., Atchison, C., Fronterre, C., Diggle, P. J., Page, A. J., Trotter, A. J., Le Viet, T., Alikhan, N.-F., O'Grady, J., The COVID-19 Genomics UK (COG-UK) Consortium, , Ashby, D., Donnelly, C., Cooke, G., Barclay, W., Ward, H., Darzi, A., Elliott, P.
10.1101/2021.05.13.21257144 — Posted: 2021-05-17
Occupation and COVID-19 mortality in England: a national linked data study of 14.3 million adults
Nafilyan, V., Pawelek, P., Ayoubkhani, D., Rhodes, S., Pembrey, L., Matz, M., Coleman, M. P., Allemani, C., Windsor-Shellard, B., van Tongeren, M., Pearce, N.
10.1101/2021.05.12.21257123 — Posted: 2021-05-17
Excess mortality during the COVID-19 pandemic: a geospatial and statistical analysis in Mogadishu, Somalia
Warsame, A., Bashiir, F., Freemantle, T., Williams, C., Vazquez, Y., Reeve, C., Aweis, A., Ahmed, M., Checchi, F., Dalmar, A.
10.1101/2021.05.15.21256976 — Posted: 2021-05-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).